Alizapride
Based on 1 publication(s) in Google Scholar
Alizapride is a potent antiemetic, acting as a dopamine receptor antagonist. Alizapride also used in human digestive disorders.
At equivalent molar concentrations, both the salt and free forms of a compound exhibit comparable biological activity. Nevertheless, the salt form (Alizapride hydrochloride) usually boasts enhanced water solubility and stability.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 59338-93-1
- Formule: C16H21N5O2
- Masse moléculaire:315.37
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
Dopamine 2 receptor
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Duncan–Hartley guinea pigs[2]
-
Dosage:2.5, 5, 10, 25 μg/kg
-
Administration:Alizapride (2.5, 5, 10, 25 μg/kg; SC; 7 consecutive days)
-
Result:Reduced the clearance of IgG-sensitized RBCs.
Chemical Information
-
CAS No. 59338-93-1
-
Masse moléculaire 315.37
-
Formule C16H21N5O2
-
SMILES
O=C(C1=C(OC)C=C(NN=N2)C2=C1)NCC3N(CC=C)CCC3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
bioRxiv
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG. [Abstract]2026 Apr 18:2026.04.17.719256. PMID: 42039650
Pureté et documentation
Références
[1]. P L Warzee, et al. Manometric study of the activity of alizapride on the motor function of the human sphincter of Oddi. J Clin Pharm Ther. 1988 Aug;13(4):281-4. [Content Brief]
[2]. Gomez, et al. Macrophage Fcgamma receptors expression is altered by treatment with dopaminergic drugs. Clinical immunology (Orlando, Fla.) vol. 90,3 (1999): 375-87. [Content Brief]
[3]. Seng, et al. Anti-emetic effect of high-dose metoclopramide vs alizapride--a randomised crossover study. British journal of clinical pharmacology vol. 38,3 (1994): 282-4. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)